Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression (Q45881054)

17 December 2017

title

Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression (English)

1 reference

17 December 2017

0 references

1 reference

Pipiya T

1

1 reference

17 December 2017

Sauthoff H

2

1 reference

17 December 2017

Huang YQ

3

1 reference

17 December 2017

Chang B

4

1 reference

17 December 2017

Cheng J

5

1 reference

17 December 2017

Heitner S

6

1 reference

17 December 2017

Chen S

7

1 reference

17 December 2017

Rom WN

8

1 reference

17 December 2017

Hay JG

9

1 reference

17 December 2017

publication date

1 June 2005

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

911-917

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302459

exact match

0 references

cites work

Replication-selective adenoviruses as oncolytic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Oncolytic biotherapy: a novel therapeutic plafform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Exploiting tumour hypoxia in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Hypoxia as a target for combined modality treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

HIF hydroxylation and cellular oxygen sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Anoxic fibroblasts activate a replication checkpoint that is bypassed by E1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Translation initiation and viral tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Methods for construction of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

7 January 2021

Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

7 January 2021

Can NMR diffusion-weighted imaging provide quantitative information on tumor interstital pO2?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

7 January 2021

Hypoxia inhibits G1/S transition through regulation of p27 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

7 January 2021

The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

7 January 2021

Progress in cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302459

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302459

1 reference

17 December 2017

Dimensions Publication ID

1048680568

0 references

1 reference

17 December 2017